PharmaKD Overview

  • Founded
  • 2004
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Buyout/​LBO
  • Financing Rounds
  • 1

PharmaKD General Information

Description

Designer and developer of PK/PD technologies to support pharmaceutical and biotechnology industries. The company provides proprietary mass spectrometry-based platforms for automated drug metabolite profiling (DMDiscovery) and biomarker discovery (MarkerScan), as well as high throughput drug-protein binding (HT PB) assays. Its technologies are used for predicting drug efficacy, drug toxicity, and monitoring disease progression.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Devices and Supplies
Other Industries
Laboratory Services (Healthcare)
Pharmaceuticals
Acquirer
Primary Office
  • 35 Cabot Road
  • Woburn, MA 01801
  • United States
+1 (781) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PharmaKD Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PharmaKD‘s full profile, request access.

Request a free trial

PharmaKD Executive Team (1)

Name Title Board Seat Contact Info
Lily Li Ph.D President
To view PharmaKD’s complete executive team members history, request access »